Evidence map›Paper›PMID 28944234›Full record

ArticleMolecular genetics & genomic medicine2017

The NextGen Study: patient motivation for participation in genome sequencing for carrier status.

Tia L Kauffman, Stephanie A Irving, Michael C Leo, Marian J Gilmore, Patricia Himes, Carmit K McMullen, Elissa Morris, Jennifer Schneider, Benjamin S Wilfond, Katrina A B Goddard

Abstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The evolving landscape of expanded carrier screening: challenges and opportunities.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tia L KauffmanCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.ORCID 0000-0002-0419-4223
Stephanie A IrvingCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.
Michael C LeoCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.
Marian J GilmoreDepartment of Medical GeneticsKaiser Permanente NorthwestPortlandOregon.
Patricia HimesDepartment of Medical GeneticsKaiser Permanente NorthwestPortlandOregon.
Carmit K McMullenCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.
Elissa MorrisCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.
Jennifer SchneiderCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.
Benjamin S WilfondDepartment of PediatricsTreuman Katz Center for Pediatric BioethicsSeattle Children's Hospital and Research InstituteUniversity of Washington School of MedicineSeattleWashington.
Katrina A B GoddardCenter for Health ResearchKaiser Permanente NorthwestPortlandOregon.

Funding

Exome sequencing in Diverse Populations in Colorado & OregonU01HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI LEO, MICHAEL C, WILFOND, BENJAMIN SIMON · 2017 to 2021
$15.7M
Clinical Implementation of Carrier Testing using NGSUM1HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GODDARD, KATRINA A., WILFOND, BENJAMIN SIMON · 2013 to 2016
$8.2M
CSER RoRC Centralized Support Coordinating CenterU01HG007307 · NHGRI · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., JARVIK, GAIL PAIRITZ · 2013 to 2016
$3.6M
NHGRI NIH HHS U01 HG007292NHGRI NIH HHS U01 HG007307NHGRI NIH HHS UM1 HG007292
6 · The paper itself

Abstract

backgroundWhile translational genomic sequencing research is increasing, few studies have been limited to healthy individuals; most have focused on patients with a disease or a strong family history of a disorder. The limited studies that have included healthy individuals have focused on the disclosure of medically actionable secondary results, rather than carrier status, to assess reproductive risks. To address this important gap, we conducted the NextGen study, which focuses on carrier status and medically actionable secondary findings in a population of women planning a pregnancy.

methodsWe assessed 310 participants' motivations for receiving genome sequencing for expanded carrier screening and experiences with familial genetic conditions that may relate to study participation.

resultsMost participants reported that obtaining general health information from genome sequencing was their primary motivator, even though they were recruited to join a study to learn more about carrier status. Forty-two percent of enrolled women became pregnant prior to obtaining sequencing results.

conclusionGenomic carrier testing may need to be offered to women prior to active pregnancy efforts to be useful for reproductive planning.

Indexed as

Decision‐makinggenetic carrier testinggeneticsgenome sequencingpreconception counselingsurvey

Identifiers

PMID28944234
PMCPMC5606895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.